Fairhope Public Library’s funding topic of upcoming APLS meeting - Alabama Reflector
2 days ago • Google News
Apellis Pharmaceuticals Inc (APLS)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 2.95B
P/E Ratio
0.00
Revenue (TTM)
$ 754.65M
Volume
0
52W High
$ 35.72
52W Low
$ 16.10
Dividend Yield
0.00%
Beta
0.72
Technicals
50-Day MA
23.9531
200-Day MA
24.327
52 Week High
35.72
52 Week Low
16.1
About APLS
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unm.
Employees
705
Headquarters
Waltham, MA
CEO
Dr. Cedric Francois M.D., Ph.D.